Robert Blum

Robert Blum serves as President & CEO at Cytokinetics. Cytokinetics operates in the research sector with approximately 600.0 employees. The company is headquartered in South San Francisco, California. Cytokinetics generates annual revenue of 8000000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • We have verified contacts for 4 executives at Cytokinetics.
• • 13,743 executive contacts are available in California.
• • Our database includes 201,469 c suite-level executives.

DNS Made Easy Rackspace MailGun Outlook Microsoft Office 365 Greenhouse.io Zendesk Bluekai Drupal Hotjar WordPress.org YouTube New Relic Google Tag Manager Google Analytics Mobile Friendly Nginx Render Remote

heart failure amyotrophic lateral sclerosis hypertrophic cardiomyopathy pharmaceuticals life sciences biotechnology: pharmaceutical preparations health care biotechnology research biopharmaceutical muscle activators muscle inhibitors therapeutics neuromuscular diseases clinical trials drug development clinical research patient advocacy muscle biology investigational medicines cardiac myosin patient-centric community engagement diversity & inclusion muscle performance muscle dysfunction medical research healthspan debilitating diseases cardiology biotech innovation clinical studies scientific publications biopharma disease management first-in-class medications medical advancements ethics in clinical trials regulatory affairs corporate responsibility investor relations health care professionals research strategy drug commercialization pipeline development patent portfolio clinical data muscle energetics post-doctoral programs internship programs community support public health biomedical research healthcare advancements disease treatment strategies cardiovascular diseases neuromuscular disorders innovative therapies muscle function muscle strength sarcomere-directed therapies precision medicine healthcare professionals research & development commercialization unmet medical needs scientific innovation therapeutic focus late-stage pipeline cardiac myosin inhibitors fast skeletal muscle troponin activators growth & metabolism partnerships collaborations value proposition healthspan improvement diverse patient populations market engagement strategies medical health wellness & fitness hospital & health care

LY

Leonard Yee Exec Asst to EVP, Chief Commercial Officer and the SVP, Head of Europe at Cytokinetics

IC

Isaac Ciechanover Chief Business Officer at Cytokinetics

AC

Andrew Callos EVP and Chief Commercial Officer at Cytokinetics

Outreach Guidance — research Sector

Executives like Robert Blum in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Cytokinetics.

How do I reach Robert Blum directly?

Robert Blum's verified email address is available to MessageCEO Pro subscribers. They currently serve as President & CEO at Cytokinetics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Robert Blum work for?

Robert Blum is President & CEO at Cytokinetics, a company in the research sector with 600.0 employees. The company is based in South San Francisco, California.

Can I pitch or sell to Robert Blum?

As President & CEO at Cytokinetics, Robert Blum is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Robert Blum directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Robert Blum in?

Robert Blum works in the research industry as President & CEO at Cytokinetics. MessageCEO provides verified contact information for executives across all major industries.

Is Robert Blum's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Robert Blum's profile is kept up-to-date with the latest available information.

Last updated: May 12, 2026